Scopolamine and Pavlovian Fear Conditioning in Rats: Dose-Effect Analysis
暂无分享,去创建一个
Michael S Fanselow | M. Fanselow | Stephen Maren | S. Anagnostaras | J. Sage | Stephan G Anagnostaras | Stephen Maren | Jennifer R Sage | Stacy Goodrich | Stacy Goodrich
[1] Y. Ichitani,et al. Effects of intrahippocampal AP5 treatment on radial-arm maze performance in rats , 1998, Brain Research.
[2] M. Fanselow,et al. Temporally Graded Retrograde Amnesia of Contextual Fear after Hippocampal Damage in Rats: Within-Subjects Examination , 1999, The Journal of Neuroscience.
[3] G. Lynch,et al. Patterned stimulation at the theta frequency is optimal for the induction of hippocampal long-term potentiation , 1986, Brain Research.
[4] M. Fanselow,et al. Scopolamine Selectively Disrupts the Acquisition of Contextual Fear Conditioning in Rats , 1995, Neurobiology of Learning and Memory.
[5] C. H. Vanderwolf,et al. Hippocampal electrical activity during waking behaviour and sleep: analyses using centrally acting drugs. , 1977, Ciba Foundation symposium.
[6] M. Fanselow,et al. NMDA processes mediate anterograde amnesia of contextual fear conditioning induced by hippocampal damage: immunization against amnesia by context preexposure. , 1994, Behavioral neuroscience.
[7] M. Fanselow,et al. Testicular hormones do not regulate sexually dimorphic Pavlovian fear conditioning or perforant-path long-term potentiation in adult male rats , 1998, Behavioural Brain Research.
[8] I. Gormezano,et al. Effects of scopolamine and methylscopolamine on classical conditioning of the rabbit nictitating membrane response. , 1983, The Journal of pharmacology and experimental therapeutics.
[9] L. Goodman,et al. The Pharmacological Basis of Therapeutics , 1941 .
[10] J. W. Rudy,et al. Cholinergic receptor blockade can impair the rat's performance on both the place learning and cued versions of the Morris water task: The role of age and pool wall brightness , 1990, Behavioural Brain Research.
[11] M. Fanselow,et al. Neurotoxic lesions of the dorsal hippocampus and Pavlovian fear conditioning in rats , 1997, Behavioural Brain Research.
[12] V. Houser,et al. Modulation of cholinergic activity and the aversive threshold in the rat. , 1974, Pharmacology, biochemistry, and behavior.
[13] M. Fanselow,et al. Retrograde abolition of conditional fear after excitotoxic lesions in the basolateral amygdala of rats: absence of a temporal gradient. , 1996, Behavioral neuroscience.
[14] I. Whishaw,et al. Cholinergic receptor blockade produces impairments in a sensorimotor subsystem for place navigation in the rat: evidence from sensory, motor, and acquisition tests in a swimming pool. , 1987, Behavioral neuroscience.
[15] Michael S. Fanselow,et al. Retrograde abolition of conditional fear after excitotoxic lesions in the basolateral amygdala of rats: absence of a temporal gradient. , 1996 .
[16] J. Grau,et al. Role of cholinergic systems in pain modulation: I. Impact of scopolamine on environmentally induced hypoalgesia and pain reactivity. , 1991, Behavioral Neuroscience.
[17] M. Mishkin,et al. Comparison of the effects of scopolamine administered before and after acquisition in a test of visual recognition memory in monkeys. , 1991, Behavioral and neural biology.
[18] Alcino J. Silva,et al. The dorsal hippocampus is essential for context discrimination but not for contextual conditioning. , 1998, Behavioral neuroscience.
[19] M. Fanselow,et al. Modality-specific retrograde amnesia of fear. , 1992, Science.
[20] Michael Davis,et al. Pharmacological and anatomical analysis of fear conditioning using the fear-potentiated startle paradigm. , 1986, Behavioral neuroscience.
[21] Michael S. Fanselow,et al. Electrolytic Lesions of the Fimbria/Fornix, Dorsal Hippocampus, or Entorhinal Cortex Produce Anterograde Deficits in Contextual Fear Conditioning in Rats , 1997, Neurobiology of Learning and Memory.
[22] J. Brown. Atropine, scopolamine and related antimuscarinic drugs , 1990 .
[23] Joseph E LeDoux,et al. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. , 1992, Behavioral neuroscience.
[24] L. Watkins,et al. Muscarinic cholinergic mediation of opiate and non-opiate environmentally induced analgesias , 1984, Brain Research.
[25] D. Amaral,et al. An analysis of the origins of the cholinergic and noncholinergic septal projections to the hippocampal formation of the rat , 1985, The Journal of comparative neurology.
[26] T R Miller,et al. Principles of therapeutics. , 1992, The Veterinary clinics of North America. Equine practice.
[27] M. Fanselow,et al. N-methyl-D-aspartate receptors in the basolateral amygdala are required for both acquisition and expression of conditional fear in rats , 1996 .
[28] J. Lisman,et al. Bidirectional synaptic plasticity induced by a single burst during cholinergic theta oscillation in CA1 in vitro , 1995, Neuron.
[29] R. Stevens,et al. Effects of scopolamine on radial maze performance in rats , 1981, Physiology & Behavior.
[30] W. Meck,et al. The organizational effects of gonadal steroids on sexually dimorphic spatial ability , 1991, Psychoneuroendocrinology.
[31] Intra-amygdala infusion of the N-methyl-D-aspartate receptor antagonist AP5 blocks acquisition but not expression of fear-potentiated startle to an auditory conditioned stimulus. , 1992, Behavioral neuroscience.
[32] M. Fanselow,et al. N-methyl-D-aspartate receptors in the basolateral amygdala are required for both acquisition and expression of conditional fear in rats. , 1996, Behavioral neuroscience.
[33] M. Fanselow,et al. Selective impairment of long-term but not short-term conditional fear by the N-methyl-D-aspartate antagonist APV. , 1992, Behavioral neuroscience.
[34] I. Grove-White,et al. An analysis of the learning deficit following hyoscine administration to man , 1973, British journal of pharmacology.
[35] Michael S. Fanselow,et al. Sex differences in hippocampal long-term potentiation (LTP) and Pavlovian fear conditioning in rats: positive correlation between LTP and contextual learning , 1994, Brain Research.
[36] M. Fanselow,et al. Differential effects of the N-methyl-D-aspartate antagonist DL-2-amino-5-phosphonovalerate on acquisition of fear of auditory and contextual cues. , 1994, Behavioral neuroscience.
[37] L. Butcher,et al. Cholinergic-dopaminergic interactions in cognitive performance. , 1990, Behavioral and neural biology.
[38] G. Lynch,et al. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5 , 1986, Nature.
[39] R. Morris,et al. Lack of task specificity and absence of posttraining effects of atropine on learning. , 1986, Behavioral neuroscience.
[40] J. Yeomans,et al. Locomotion and stereotypy induced by scopolamine: contributions of muscarinic receptors near the pedunculopontine tegmental nucleus , 1997, Brain Research.
[41] J. W. Rudy,et al. Scopolamine Administered before and after Training Impairs both Contextual and Auditory-Cue Fear Conditioning , 1996, Neurobiology of Learning and Memory.
[42] The startled seahorse: Is the hippocampus necessary for contextual fear conditioning? , 1998 .
[43] Richard F. Thompson,et al. Parallel augmentation of hippocampal long-term potentiation, theta rhythm, and contextual fear conditioning in water-deprived rats , 1994 .
[44] M. Fanselow,et al. Parallel augmentation of hippocampal long-term potentiation, theta rhythm, and contextual fear conditioning in water-deprived rats. , 1994, Behavioral neuroscience.
[45] G. Collingridge,et al. Excitatory amino acids in synaptic transmission in the Schaffer collateral‐commissural pathway of the rat hippocampus. , 1983, The Journal of physiology.
[46] Selective impairment of long-term but not short-term conditional fear by the N-methyl-D-aspartate antagonist APV. , 1992 .
[47] M. Fanselow,et al. N-methyl-D-aspartate receptor antagonist APV blocks acquisition but not expression of fear conditioning. , 1991, Behavioral neuroscience.
[48] R. Bolles,et al. Naloxone and shock-elicited freezing in the rat. , 1979 .
[49] J. Roder,et al. Mice Lacking Metabotropic Glutamate Receptor 5 Show Impaired Learning and Reduced CA1 Long-Term Potentiation (LTP) But Normal CA3 LTP , 1997, The Journal of Neuroscience.